Orthofix Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Orthofix Medical Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue799.49746.64460.71464.48406.56459.96453.04
Cost of Revenue253.61224.32123.54114.91101.89100.6196.63
Gross Profit545.89522.32337.17349.57304.67359.35356.41
Operating Expenses
Research & Development73.6480.2349.0749.6239.0634.6433.22
Selling, General & Administrative532.53530.40308.78290.67272.38309.28288.78
Operating Expenses630.50628.08357.84322.70318.24309.71322.00
Operating Income-84.62-105.77-13.27-8.32-13.57-18.7834.42
Other Income/Expense
Interest Income0.000.000.000.000.000.000.00
Interest Expense29.63-8.631.29-1.84-2.480.000.83
Other Income/Expense-39.26-2.004.253.348.388.14-10.71
Income
Income Before Tax-123.88-148.68-17.71-13.50-0.37-27.0522.89
Income Tax Expense2.122.722.0424.88-2.891.419.07
Net Income-126.00-151.40-19.75-38.382.52-28.4613.81
Net Income - Continuous Operations-126.00-151.40-19.75-38.380.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-34.18-45.2115.6421.4420.710.7543.40
EBIT-94.24-105.77-16.42-11.66-13.57-27.7323.71
Depreciation & Amortization60.0660.5629.0229.6034.2824.700.00
Earnings Per Share
Basic EPS-3.00-4.00-1.00-2.00--2.001.00
Diluted EPS-3.00-4.00-1.00-2.00--2.001.00
Basic Shares Outstanding38.1336.7320.0519.6919.2718.9018.49
Diluted Shares Outstanding38.1336.7320.0519.6919.3918.9018.91